Diabetic wounds are a significant complication of diabetes that is characterized by delayed wound healing and a high risk of amputation. Pro‐inflammatory macrophages (M1) and Matrix Metallo protease‐9 (MMP‐9) overexpression play pivotal roles in the extended inflammatory phase observed in diabetic wounds. This study developed a multifunctional lipid nanoemulsion containing quercetin and rosemary oil (Q‐RLNE) that can efficiently convert M1 macrophages to M2, inhibit MMP‐9, and prevent microbial infection, accelerating diabetic wound healing. In‐vitro studies demonstrated that Q‐RLNEs showed excellent biocompatibility and cellular uptake. Additionally, Q‐RLNEs demonstrated effective ROS scavenging, macrophage polarization, MMP‐9 inhibition, and excellent anti‐microbial properties against Staphylococcus aureus (S. aureus). In‐vivo results demonstrated that Q‐RLNE can accelerate and achieve complete wound healing in diabetic‐induced rats by reducing inflammation and promoting angiogenesis with proper collagen deposition and dermal projection regeneration. This study also highlighted the application of the Segment Anything Model (SAM) for precise wound region segmentation. SAM combines attention‐fusion and hybrid fusion strategies for accurate segmentation, enabling comprehensive analysis of wound attributes over time and guiding treatment decisions. The SAM analysis results also align with Q‐RLNE in‐vitro and in‐vivo. The findings of this study suggest that Q‐RLNE is a promising new therapeutic agent for accelerating diabetic wound healing.This article is protected by copyright. All rights reserved